Recombinant factor VIIa for uncontrollable bleeding in patients with extracorporeal membrane oxygenation: report on 15 cases and literature review

INTRODUCTION: Bleeding is the most frequent complication in patients receiving venoarterial or venovenous extracorporeal membrane oxygenation (ECMO). Recombinant activated factor VII (rFVIIa) has been used in these patients with conflicting results. We describe our experience with rFVIIa for refract...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Repessé, Xavier, Au, Siu Ming, Bréchot, Nicolas, Trouillet, Jean-Louis, Leprince, Pascal, Chastre, Jean, Combes, Alain, Luyt, Charles-Edouard
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4057417/
https://ncbi.nlm.nih.gov/pubmed/23531278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc12581
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados